Bedel Financial Consulting, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Bedel Financial Consulting, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$548.35 - $738.84 $8,225 - $11,082	-15 Closed	0 $0
Q3 2020 Oct 20, 2020	SELL	$544.75 - $658.21 $2,723 - $3,291	-5 Reduced 25.0%	15 $8,000
Q1 2020 May 06, 2020	BUY	$336.18 - $494.43 $1,680 - $2,472	5 Added 33.33%	20 $10,000
Q4 2019 Jan 28, 2020	SELL	$274.13 - $376.51 $6,579 - $9,036	-24 Reduced 61.54%	15 $6,000
Q2 2018 Jul 18, 2018	BUY	$284.6 - $344.99 $6,830 - $8,279	24 Added 160.0%	39 $13,000
Q1 2018 May 03, 2018	BUY	$315.82 - $393.78 $4,737 - $5,906	15 New	15 $5,000

1,463

84.5M

907K

1.3M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $112B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Bedel Financial Consulting, Inc., based on Form 13F filings with the SEC.

Stay updated on Bedel Financial Consulting, Inc. with notifications on news.